Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00420407 · ClinicalTrials.gov registry record · Early Phase 1
Low Dose Vasopressin in Traumatic Shock
A Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 81
- Enrollment target
NCT00420407: Clinical Trial Early Phase 1 study, sponsored by The University of Texas Health Science Center at San Antonio.
NCT00420407 is a Early Phase 1 study that was terminated before completion, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 81 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00420407, a Early Phase 1 study, was terminated before completion, sponsored by The University of Texas Health Science Center at San Antonio.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 81 participants
- Enrollment target
Study Summary
Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.
Primary Outcome
Survival of a traumatic injury subject to at least 30 days after admission to the emergency room.
Interventions
- DRUG normal saline control
- DRUG vasopressin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2007-02 |
| Est. Completion | 2011-02 |
| Phase | Early Phase 1 |
Why NCT00420407 stopped before completion
NCT00420407 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (53% higher).
The record links to 0 conditions, and to 2 interventions - of which normal saline control is the first listed.
NCT00420407 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00420407 about?
NCT00420407 is a clinical study titled "Low Dose Vasopressin in Traumatic Shock". Hypothesis: We hypothesize that resuscitation regimens which minimize the total volume of resuscitation fluid, while restoring organ perfusion, will lead to lower morbidity and mortality in critically ill patients following trauma.
What is the current status of trial NCT00420407?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 81 participants. The study started on 2007-02. Estimated completion is 2011-02.
What interventions are being tested in trial NCT00420407?
The interventions under investigation include: normal saline control (DRUG), vasopressin (DRUG).
Who is sponsoring clinical trial NCT00420407?
This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00420407's enrollment target sits among peer trials
81 269th of 2000 higher than 1,730 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia